Liquid Biopsy in Cancer Diagnostics Market Report

China Liquid Biopsy in Cancer Diagnostics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 14, 2023
  • PAGES：169
  • REPORT CODE：GMM1797409
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Liquid Biopsy in Cancer Diagnostics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Biocartis

    • SAGA Diagnostics

    • Neogenomics Laboratories

    • Myriad Genetics Inc

    • Biocept Inc

    • Agilent Technologies Inc

    • QIAGEN

    • Agena Bioscience Inc

    • Illumina Inc

    • MDx Health

    • Thermo Fisher Scientific Inc

    • Sysmex Corporation

    • Lucence Health Inc

    • Bio-Techne

    • Guardant Health

    • F Hoffmann-La Roche AG

    By Type:

    • Instruments

    • Reagents & Kits

    By Application:

    • Breast Cancer

    • Colon Cancer

    • Others

    • Lung Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Liquid Biopsy in Cancer Diagnostics Market Overview 2018-2029

    • 1.1 China Liquid Biopsy in Cancer Diagnostics Industry Development Overview

    • 1.2 China Liquid Biopsy in Cancer Diagnostics Industry Development History

    • 1.3 China Liquid Biopsy in Cancer Diagnostics Industry Market Size (2018-2029)

    • 1.4 China Liquid Biopsy in Cancer Diagnostics Market Analysis by Type from Production Side

      • 1.4.1 China Liquid Biopsy in Cancer Diagnostics Production Volume, Production Value and Growth Rate of Instruments (2018-2029)

      • 1.4.2 China Liquid Biopsy in Cancer Diagnostics Production Volume, Production Value and Growth Rate of Reagents & Kits (2018-2029)

    • 1.5 China Liquid Biopsy in Cancer Diagnostics Market Analysis by Application from Consumption End

      • 1.5.1 China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.2 China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Colon Cancer (2018-2029)

      • 1.5.3 China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.4 China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • 1.6 China Liquid Biopsy in Cancer Diagnostics Market Analysis by Region

      • 1.6.1 North China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Liquid Biopsy in Cancer Diagnostics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Liquid Biopsy in Cancer Diagnostics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Liquid Biopsy in Cancer Diagnostics Market Status and Competition Analysis in 2023

      • 2.2.3 China Liquid Biopsy in Cancer Diagnostics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Liquid Biopsy in Cancer Diagnostics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Liquid Biopsy in Cancer Diagnostics Industry Development

    Chapter 3 Liquid Biopsy in Cancer DiagnosticsIndustry Chain Analysis

    • 3.1 Liquid Biopsy in Cancer Diagnostics Industry Chain

    • 3.2 Liquid Biopsy in Cancer Diagnostics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Liquid Biopsy in Cancer Diagnostics Market

    • 3.3 Liquid Biopsy in Cancer Diagnostics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Liquid Biopsy in Cancer Diagnostics Market

    Chapter 4 China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 4.1 China Liquid Biopsy in Cancer Diagnostics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Liquid Biopsy in Cancer Diagnostics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Liquid Biopsy in Cancer Diagnostics Production Volume and Growth Rate, by Type

      • 4.5.1 China Liquid Biopsy in Cancer Diagnostics Production Volume and Growth Rate of Instruments

      • 4.5.2 China Liquid Biopsy in Cancer Diagnostics Production Volume and Growth Rate of Reagents & Kits

    Chapter 5 China Liquid Biopsy in Cancer Diagnostics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Liquid Biopsy in Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate, by Application

      • 5.5.1 China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Breast Cancer

      • 5.5.2 China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Colon Cancer

      • 5.5.3 China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Others

      • 5.5.4 China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Lung Cancer

    Chapter 6 China Liquid Biopsy in Cancer Diagnostics Market, by Region

    • 6.1 China Liquid Biopsy in Cancer Diagnostics Production Volume and Production Value, by Region

    • 6.2 China Liquid Biopsy in Cancer Diagnostics Sales Volume and Sales Value, by Region

    Chapter 7 North China Liquid Biopsy in Cancer Diagnostics Market Analysis

    • 7.1 North China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 7.2 North China Liquid Biopsy in Cancer Diagnostics Market, by Application

    Chapter 8 Central China Liquid Biopsy in Cancer Diagnostics Market Analysis

    • 8.1 Central China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 8.2 Central China Liquid Biopsy in Cancer Diagnostics Market, by Application

    Chapter 9 South China Liquid Biopsy in Cancer Diagnostics Market Analysis

    • 9.1 South China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 9.2 South China Liquid Biopsy in Cancer Diagnostics Market, by Application

    Chapter 10 East China Liquid Biopsy in Cancer Diagnostics Market Analysis

    • 10.1 East China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 10.2 East China Liquid Biopsy in Cancer Diagnostics Market, by Application

    Chapter 11 Northeast China Liquid Biopsy in Cancer Diagnostics Market Analysis

    • 11.1 Northeast China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 11.2 Northeast China Liquid Biopsy in Cancer Diagnostics Market, by Application

    Chapter 12 Southwest China Liquid Biopsy in Cancer Diagnostics Market Analysis

    • 12.1 Southwest China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 12.2 Southwest China Liquid Biopsy in Cancer Diagnostics Market, by Application

    Chapter 13 Northwest China Liquid Biopsy in Cancer Diagnostics Market Analysis

    • 13.1 Northwest China Liquid Biopsy in Cancer Diagnostics Market, by Type

    • 13.2 Northwest China Liquid Biopsy in Cancer Diagnostics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Biocartis

        • 14.1.1 Biocartis Company Profile

        • 14.1.2 Biocartis Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 SAGA Diagnostics

        • 14.2.1 SAGA Diagnostics Company Profile

        • 14.2.2 SAGA Diagnostics Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Neogenomics Laboratories

        • 14.3.1 Neogenomics Laboratories Company Profile

        • 14.3.2 Neogenomics Laboratories Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Myriad Genetics Inc

        • 14.4.1 Myriad Genetics Inc Company Profile

        • 14.4.2 Myriad Genetics Inc Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Biocept Inc

        • 14.5.1 Biocept Inc Company Profile

        • 14.5.2 Biocept Inc Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Agilent Technologies Inc

        • 14.6.1 Agilent Technologies Inc Company Profile

        • 14.6.2 Agilent Technologies Inc Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 QIAGEN

        • 14.7.1 QIAGEN Company Profile

        • 14.7.2 QIAGEN Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Agena Bioscience Inc

        • 14.8.1 Agena Bioscience Inc Company Profile

        • 14.8.2 Agena Bioscience Inc Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Illumina Inc

        • 14.9.1 Illumina Inc Company Profile

        • 14.9.2 Illumina Inc Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 MDx Health

        • 14.10.1 MDx Health Company Profile

        • 14.10.2 MDx Health Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Thermo Fisher Scientific Inc

        • 14.11.1 Thermo Fisher Scientific Inc Company Profile

        • 14.11.2 Thermo Fisher Scientific Inc Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 Sysmex Corporation

        • 14.12.1 Sysmex Corporation Company Profile

        • 14.12.2 Sysmex Corporation Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 Lucence Health Inc

        • 14.13.1 Lucence Health Inc Company Profile

        • 14.13.2 Lucence Health Inc Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Bio-Techne

        • 14.14.1 Bio-Techne Company Profile

        • 14.14.2 Bio-Techne Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Guardant Health

        • 14.15.1 Guardant Health Company Profile

        • 14.15.2 Guardant Health Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 F Hoffmann-La Roche AG

        • 14.16.1 F Hoffmann-La Roche AG Company Profile

        • 14.16.2 F Hoffmann-La Roche AG Liquid Biopsy in Cancer Diagnostics Market Performance

        • 14.16.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Liquid Biopsy in Cancer Diagnostics Industry Research Conclusions

    • 15.2 Liquid Biopsy in Cancer Diagnostics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Liquid Biopsy in Cancer Diagnostics Industry Market Size (2018-2029)

    • Figure China Liquid Biopsy in Cancer Diagnostics Production Volume, Production Value and Growth Rate of Instruments (2018-2029)

    • Figure China Liquid Biopsy in Cancer Diagnostics Production Volume, Production Value and Growth Rate of Reagents & Kits (2018-2029)

    • Figure China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Colon Cancer (2018-2029)

    • Figure China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Liquid Biopsy in Cancer Diagnostics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure North China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Central China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure South China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure East China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate from 2018-2029

    • Figure Liquid Biopsy in Cancer Diagnostics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Share by Type in 2018

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Share by Type in 2023

    • Figure China Liquid Biopsy in Cancer Diagnostics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Production Volume and Growth Rate of Instruments (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Production Volume and Growth Rate of Reagents & Kits (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Share by Application in 2018

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Share by Application in 2023

    • Figure China Liquid Biopsy in Cancer Diagnostics Total Market Size and Growth Rate from Consumption End

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Colon Cancer (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Production Volume by Region (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Region (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Production Value by Region (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Production Value Share by Region (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Sales Volume by Region (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Region (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Sales Value by Region (2018-2023)

    • Table China Liquid Biopsy in Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Figure China Liquid Biopsy in Cancer Diagnostics Sales Value Share by Region (2018-2023)

    • Table North China Liquid Biopsy in Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table North China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure North China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table North China Liquid Biopsy in Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table North China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure North China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Central China Liquid Biopsy in Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Central China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Central China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Central China Liquid Biopsy in Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Central China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Central China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table South China Liquid Biopsy in Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table South China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure South China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table South China Liquid Biopsy in Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table South China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure South China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table East China Liquid Biopsy in Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table East China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure East China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table East China Liquid Biopsy in Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table East China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure East China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Liquid Biopsy in Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northeast China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northeast China Liquid Biopsy in Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northeast China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Liquid Biopsy in Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Southwest China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Southwest China Liquid Biopsy in Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Southwest China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Liquid Biopsy in Cancer Diagnostics Production Volume by Type (2018-2023)

    • Table Northwest China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Liquid Biopsy in Cancer Diagnostics Production Volume Share by Type (2018-2023)

    • Table Northwest China Liquid Biopsy in Cancer Diagnostics Sales Volume by Application (2018-2023)

    • Table Northwest China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Liquid Biopsy in Cancer Diagnostics Sales Volume Share by Application (2018-2023)

    • Table Biocartis Company Profile

    • Table Biocartis Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table SAGA Diagnostics Company Profile

    • Table SAGA Diagnostics Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Neogenomics Laboratories Company Profile

    • Table Neogenomics Laboratories Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Myriad Genetics Inc Company Profile

    • Table Myriad Genetics Inc Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Biocept Inc Company Profile

    • Table Biocept Inc Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Agilent Technologies Inc Company Profile

    • Table Agilent Technologies Inc Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table QIAGEN Company Profile

    • Table QIAGEN Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Agena Bioscience Inc Company Profile

    • Table Agena Bioscience Inc Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Illumina Inc Company Profile

    • Table Illumina Inc Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table MDx Health Company Profile

    • Table MDx Health Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Thermo Fisher Scientific Inc Company Profile

    • Table Thermo Fisher Scientific Inc Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Sysmex Corporation Company Profile

    • Table Sysmex Corporation Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Lucence Health Inc Company Profile

    • Table Lucence Health Inc Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Bio-Techne Company Profile

    • Table Bio-Techne Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table Guardant Health Company Profile

    • Table Guardant Health Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)

    • Table F Hoffmann-La Roche AG Company Profile

    • Table F Hoffmann-La Roche AG Liquid Biopsy in Cancer Diagnostics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US